Regeneron and Phlexglobal share a blueprint for a highly effective partnering model that is producing measurable benefits, from improved TMF quality, completeness, and timeliness, to process innovation that increases efficiency and frees busy study teams from rote work.
Often overlooked, the management of established marketed products can benefit from outsourcing as pressure grows to sustain revenue while keeping maintenance costs low. Explore a proven methodology for ensuring compliance and reducing risk when managing established product portfolios.
Unlock the full potential of your product and optimize your investments with this step-by-step guide to commercialization. Obtain valuable insights to help you navigate the market and maximize the impact of your therapy, plus six key considerations for commercializing your CGT asset.
As pharmaceutical companies rely more on outsourcing partners to maintain marketed products, ensuring efficiency and reliability becomes crucial. Discover how the integration of digitalization, such as automation and AI, is instrumental in optimizing outsourcing relationships.
Technology transfer encompasses two primary types: scale-up and transfer to a different site. Gain deeper insights into technology transfer and essential factors for achieving success.
Maintaining timely and accurate safety document distribution to health authorities is consuming more time and resources than ever. Find out how companies are freeing up safety and clinical teams — while improving speed and accuracy — by leveraging technology-elevated expert providers.
